1 / 21

Paramyxoviruses; Rubella

Paramyxoviruses; Rubella. Chapter 40. Paramyxoviruses. Features ssRNA viruses Nonsegmented , ~15 kb Enveloped Hemagglutinin glycoprotein Fusion glycoprotein Labile, but highly infections Major classification ( Paramyxovirinae ) Respirovirus (parainfluenza viruses)

ardice
Télécharger la présentation

Paramyxoviruses; Rubella

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Paramyxoviruses; Rubella • Chapter 40

  2. Paramyxoviruses • Features • ssRNA viruses • Nonsegmented, ~15 kb • Enveloped • Hemagglutinin glycoprotein • Fusion glycoprotein • Labile, but highly infections • Major classification (Paramyxovirinae) • Respirovirus (parainfluenza viruses) • Rubulavirus (mumps, parainfluenza viruses) • Morbillivirus (measles) • Henipavirus (Hendra and Nipah viruses) • Pnuemovirus (respiratory syncytial virus) • Metapneumovirus (metapneumovirus)

  3. Measles • Symptoms • Begins with fever, runny nose, cough, red weepy eyes • Fine rash appears within a few days • Appears first on forehead, then spreads to rest of body • Symptoms generally disappear within 1 week • Many cases complicated by secondary infections • Pneumonia and earaches are most common secondary conditions • Less common complications include encephalitis and subacute sclerosing panencephalitis (SSPE) • Measles does not kill; instead, it leads to secondary infections that do kill

  4. Measles • Pathogenesis • Infection via respiratory route • Virus replicates in epithelium of upper respiratory tract • Spreads to lymph nodes • Further replication occurs here • Spreads to all parts of the body • Infected mucous membranes important diagnostic sign • Membranes covered with Koplik spots • White spots seen in back of throat opposite molars • Infected membranes may explain increased susceptability to secondary infection • Especially to middle ear and lungs • Skin rash is due to effects of virus replication within skin cells • Rash also due to cellular immune response to viral antigens in the skin

  5. Measles • Epidemiology • Humans are only natural host • Virus spread by respiratory droplets • Before routine immunization, over 99% of population infected • Vaccine resulted in decline of annual cases • Measles is no longer endemic in United States • Outbreaks still occur and are due to susceptible populations • Populations include • Children too young to be vaccinated • Preschool children never vaccinated • Children and adults inadequately vaccinated • Persons not vaccinated for religious or medical reasons • Prevention and Treatment • Prevention by vaccination • Vaccine is usually given in conjunction with mumps and rubella vaccine • MMR

  6. Measles • Measles virulence factors • P protein • Transcription factor for cellular enzyme A20 • A20 negatively regulates NF-κB • NF-κB activates antiviral responses in infected cells • V protein • Blocks JAK phosphorylation of STAT1 • Blocks STAT1/STAT2 dimerization • C protein interferes with PKR

  7. Measles as a Global Health Problem • Measles occurs predominantly in Africa and Asia • In 2000, there were more than 700,000 deaths per year from measles • The great majority of these deaths were children • In 2001 the Measles Initiative was started by the WHO • Deaths in 2005 were 454,000 • Deaths in 2010 were 164,000 • A 90% reduction is targeted by 2010 (from 2000 levels) • Vigorously supported by Rotary International

  8. Rubella • Aka - German Measles • Typically mild • Often unrecognized • Difficult to diagnose • Significant infection in pregnant women • Symptoms • Slight fever with mild cold symptoms • Enlarged lymph nodes behind ears and back of neck • Faint rash on face • Rash consists of light pink spots • Adults commonly complain of joint pain • Symptoms last only a few days • Joint pain may last up to 3 weeks • Congenital rubella syndrome • First trimester susceptibility highest • Can lead to fetal death, or neurological disease in survivors (deafness, mental retardation)

  9. Rubella • Causative Agent • Rubella virus • Member of Togaviridae family • Small, enveloped • Single-stranded RNA genome • Pathogenesis • Enters body via respiratory route • Virus multiplies in nasopharynx, then enters bloodstream • Causes sustainedviremia • Blood transports virus to body tissues • Immunity develops against viral antigens resulting antigen-antibody complexes most likely responsible for rash and joint pain

  10. Rubella • Epidemiology • Humans are only natural host • Disease is highly contagious • Less so than measles • 40% of infected people fail to develop symptoms • These individuals can spread virus • Infectious 7 days before appearance of rash to 7 days after • Prevention and Treatment • Vaccination with attenuated rubella virus vaccine • Administered at 12 months and boosted at 4 to 6 years of age • Produces long-lasting immunity in 95% of recipients • Vaccine not given to pregnant women due to potential complications • Women are advised not to become pregnant for 28 days post vaccination • Vaccine has significantly reduced incidence in United States

  11. Mumps • Causative Agent • Mumps virus • Member of the Paramyxoviridae family • Enveloped • Single stranded RNA genome • Symptoms • Early symptoms • Fever with loss of appetite and headache • Later symptoms • Painful swelling of one or both parotid glands and spasms • Usually makes it difficult to chew and swallow • Symptoms disappear in about a week • Symptoms much more severe in individuals past puberty • Post-pubertal males can suffer painful swelling of testicles • Ovarian involvement occurs in about 20% of cases • Pregnant women often miscarry

  12. Mumps • Pathogenesis • Transmitted by inhalation of infected droplets • Long incubation period • 15 to 20 days • Virus replicates in the upper respiratory tract • Virus spreads throughout body via bloodstream • Produces symptoms after infecting tissues • In salivary glands • Virus multiplies in epithelium of salivary ducts • Destroys epithelium and releases virus into saliva • Inflammation produced • Inflammation responsible for symptoms and pain

  13. Mumps • Epidemiology • Humans only natural host • Natural infection confers lifelong immunity • Virus is spread by asymptomatic individuals in high numbers • Virus can be present in saliva of symptomatic persons • Prevention and Treatment • Prevention directed at immunization • Usually given in same injection as measles and rubella • MMR • Immunization prevents latent recurrent infections • Due to only one viral serotype • No effective antiviral treatment

  14. Henipaviruses • Members • Hendra virus (HeV; Australia) • Nipah virus (NiV; Asia) • Paramyxoviruses • Subfamily Paramyxovirinae • Bat viruses • Genus Pteropus (flying foxes) • Genome organization • Negative strand RNA • HeV - 18.2 nt • NiP - 27 nt • Six genes • N - nucleocapsid • P - phosphoproteins • M - matrix protein • F - fusion protein • G - glycoprotein (mediates attachment) • L - Large polymerase

  15. Henipaviruses

  16. Henipaviruses

  17. Henipaviruses • Features • Only zoonotic paramyxoviruses • Infections • Bats • Humans • Horses • Pigs • Dogs • Ferrets • Raccoons • Lions • Hamsters • 2004 Bangladesh outbreak: 75% fatality rate • BSL-4 pathogens and select agents

  18. Henipaviruses

  19. Henipaviruses • Infections • Bats - no apparent pathology • Horses (HeV) and pigs (NiV) • Respiratory transmission (communicable) • Neurological manifestations • Facial swelling • Nasal discharge • Humans • Respiratory transmission (communicable) • Severe acute encephalitis • NiV manifestations can occur up to 4 years post infection • Relapse encephalitis

  20. Henipaviruses • Molecular biology of infection • G protein • Provides broad species tropism • Along with F protein can induce fusion of cells from different species • Cellular receptor is ephrin B2 protein • Neurons • Smooth muscle • Capillary endothelial cells • F protein • Single polypeptide (F0) is cleaved into F1 and F2 by cellular furin protease in the Golgi • F1 and F2 are disulfide-linked on virus membrane to form F protein • P gene • Single polypeptide cleaved into P, V and W proteins • P and V interact with and disable STAT1 transcription factor • W interacts with and disables IRF-3 transcription factor • These events disable the type I IFN pathway of infected cells

More Related